Then, the patients were divided into high- and low-expression groups based on the median mRNA expression level of ARPC5, and we further conducted Kaplan–Meier survival analysis to explore the correlation between ARPC5 expression and DFS of HCC patients. Here, ARPC5 is linked to hepatocellular carcinoma.